COVID-19 Created 55 Multi-Billion Dollar Business Opportunities, Totaling* $1.38 - 1.94 Trillion

WASHINGTON, June 22, 2020 /PRNewswire/ -- According to HSRC's most recently published landmark report, "COVID-19 Pandemic Mitigation Products Market - 2020-2024," the coronavirus, which has unbridled an economic disaster, unparalleled in scope and scale, with lockups, supply chain interruptions and laying off of millions globally, has also created an unexpected market worth $1.38 - $1.94 Trillion during 2020-2024.

The economic recovery will depend on how well healthcare, community, and governments will use the COVID-19 mitigation products to curb the spread of the pandemic to minimize new surges so that the economy will recover. The products and services of this new market will fight the pandemic and minimize the impact of a catastrophic economic downturn. 

As countries start to re-open, the report brings to your attention multi-billion-dollar business opportunities that may assist multiple industry sectors struggling to retain business continuity and growth. This newly formed market is not limited to the healthcare industry (like the pharma industry). Many business opportunities are being created by the pandemic for other industries from contact tracing systems to blockchain, from AI, big data & deep learning to nonwoven fabrics.

Furthermore, the COVID-19 Pandemic Mitigation Products Market - 2020-2024 report presents a thorough market analysis of 54 products & services, 6 vertical, 4 revenue source, 5 regional and 13 national markets providing in-depth analysis of this newly formed market.

This 1020-page, 5-volume market mega report is the first and most comprehensive review of the new global COVID-19 pandemic mitigation products & services market available today. As countries start to re-open, and you do your best to recover your business, the report brings to your attention multi-billion-dollar business opportunities that may assist your struggle to retain business continuity and growth. This newly formed market is not limited to the healthcare industry; many business opportunities are being created for industries from geo-surveillance to blockchain, from AI, big data & deep learning to nonwoven fabrics.

To adhere to our high standards of research, as nobody can truly forecast the future of this on-going pandemic, we include in the report two scenarios:

1. Optimistic scenario – assumes (among other things) that mass vaccination will commence by July 2021
2. Conservative scenario – assumes (among other things) that no mass vaccination will be available until 2025

The objective of this report is to provide today's strategic decision-makers with an expert 360-degree, time-sensitive, detailed view of this interconnected market and provides answers to questions such as:

• What is the COVID-19 pandemic mitigation products & services market size and what are the forecasted trends during 2020-2024?
• What are the most attractive business opportunities?
• What drives the customers to purchase solutions and services?
• What are the COVID-19 Mitigation technology & services trends?
• What will be the 212 sub-markets' sizes over the 2020-2024 period?
• What are the challenges to market penetration & growth?  

Download the ToC of the report at  >>>

With a highly fragmented market we address the "money trail" – each dollar spent in the global COVID-19 Pandemic Mitigation market is analyzed and crosschecked via 5 orthogonal viewpoints:

• 55 products and services:

• 6 vertical markets
• Hospitals & Surge Hospitals
• Clinical Labs
• Clinics
• Emergency Medical Services (EMS)
• Homecare & Nursing Homes
• Research Bodies
• 13 National Markets:
• USA
• Canada
• UK
• Germany
• France
• Italy
• Rest of Europe
• India
• China
• South Korea
• Japan
• Rest of Asia Pacific
• RoW
• 5 Regional Markets:
• North America
• Latin America
• Europe
• Middle East & Africa
• Asia Pacific
• 4 Revenue Source Markets:
• Product Sales
• Training Services
• Planning & Consulting
• Maintenance & Upgrades

For more information, or to purchase a copy, please visit us here.

Note - (*)Annual market size is scenario and year dependent

About the analysts that composed this report:
The team which composed this report brings 43 years of hands on record in the development and commercialization of healthcare products including: antibody antigen detection, E-health, Bio-decontamination and biosecurity, PACS, teleradiology, PPE, computerized tomography, medical devices, and brings long term cooperation with the FDA and CDC as well as the EU CE and other national medical legislation agencies.

As early as January 20, 2020 we recruited all our analysts to research the COVID-19 pandemic mitigation related products & services purchases. We interviewed hundreds of experts, participated in more than 95 conferences and webinars, reviewed more than 1,500 publications and interviewed executives of more than 65 pandemic related companies.

About Homeland Security Research Corp. (HSRC)

Homeland Security Research Corp. (HSRC) is an international market and technology research firm specializing in the Public Safety Industry. HSRC provides premium off-the-shelf and customized market reports on present and emerging technologies and industry expertise, enabling global clients to gain time-critical insight into business opportunities. HSRC's clients include the U.S. Congress, DHS, U.S. Army, U.S. Navy, DOD, DOT, GAO, NATO and EU, among others; as well as government agencies in Japan, Korea, Taiwan, Israel, Canada, UK, Germany, Australia, Sweden, Finland, Singapore. With over 950 private sector clients (76% returning), including major defense and security contractors and Fortune 2000 companies, HSRC earned the reputation as the industry's Gold Standard for public safety market reports.

Washington D.C. 20004, 601 Pennsylvania Ave., NW Suite 900,
Tel: 202-455-0966, [email protected],  https://homelandsecurityresearch.com

SOURCE Homeland Security Research Corp. (HSRC)

Related Links

http://www.homelandsecurityresearch.com